Kelsey Watts, Ph.D.

About
Kelsey Watts is a postdoctoral fellow in Mete Civelek’s lab focused on understanding and testing novel treatments for coronary artery disease. She is involved in a clinical trial with the head of UVA’s Women’s Heart Health Care Center, Dr. Patricia Rodriguez-Lozano, to investigate the use of an SGLT2i to treat inflammation in women with nonobstructive coronary artery disease. Additionally, through collaborations with the Leducq network AtheroGen, she is aims to identify transcriptomic mechanisms that govern known sex differences in plaque stability. Her holistic training includes expertise in wet lab, computational and clinical research.
As a postdoc at UVA, Watts has been funded by a T32 training grant (2023-2025) through the Cardiovascular Research Center. She was also awarded an AHA Postdoctoral Fellowship (2025-2027). Additionally, Watts received several awards to fund her research, including the UVA Wallace H. Coulter Center for Translational Research Postdoc Scholar Award (2024-2025) and the AtheroGen Leducq Junior Investigator Award (2024 and 2025).
Watts received her Ph.D. in Bioengineering from Clemson University training in the lab of Dr. Will Richardson. Her dissertation research focused on uncovering sex-specific mechanisms of cardiac fibrosis, specifically the influence of estrogen. Kelsey also has a strong interest in making STEM education more inclusive. She completed a Certificate in Engineering and Science Education from Clemson during her Ph.D. training and developed education modules and lesson plans in systems biology for those new to computational biology approaches.
Education
Ph.D. Bioengineering, Clemson University, 2022
B.S. Biomedical Engineering, The Ohio State University 2017